Biased Iglambda expression in hypermutated IgD multiple myelomas does not result from receptor revision

Leukemia. 2002 Jul;16(7):1358-61. doi: 10.1038/sj.leu.2402513.

Abstract

Normal IgM(-)IgD(+) CD38(+) B cells and IgM(-)IgD(+) multiple myelomas (MM) are characterized by Cmu deletion, biased Iglambda expression and hypermutated IgV regions. The predominant Iglambda usage has been proposed as resulting from secondary Ig gene rearrangements during extensive clonal expansion in the germinal center environment. Here, four cases of IgDlambda MM were studied to address the question of light chain receptor revision in a 'single cell' model. Detailed analyses of both IGK and IGL alleles of each case were performed by Southern blotting, (RT-) PCR, and sequencing. The expressed IgV genes were extensively mutated and Cmu deletion was confirmed in two cases. In addition, in the four MM a total of six non-functional deletional IGK rearrangements were identified, which proved to be unmutated. We conclude that IgD myelomas indeed originate from (post) germinal center B cells in which, in spite of the fact that they are hypermutated, there is no evidence of receptor revision.

MeSH terms

  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology
  • Base Sequence
  • Gene Rearrangement, B-Lymphocyte, Light Chain
  • Humans
  • Immunoglobulin D / genetics*
  • Immunoglobulin Light Chains / genetics*
  • Immunoglobulin lambda-Chains / biosynthesis
  • Immunoglobulin lambda-Chains / genetics*
  • Molecular Sequence Data
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / immunology
  • Mutation
  • Receptors, Antigen, B-Cell / genetics

Substances

  • Immunoglobulin D
  • Immunoglobulin Light Chains
  • Immunoglobulin lambda-Chains
  • Receptors, Antigen, B-Cell